Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy
Jun Li, Peng-Wen Wu, Yuan Zhou, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma
Fang Huang, Bing-Rong Wang, Yigang Wang
World Journal of Gastroenterology (2018) Vol. 24, Iss. 41, pp. 4643-4651
Open Access | Times Cited: 179
AGE-RAGE synergy influences programmed cell death signaling to promote cancer
Bhargav N. Waghela, Foram U. Vaidya, Kishu Ranjan, et al.
Molecular and Cellular Biochemistry (2020) Vol. 476, Iss. 2, pp. 585-598
Closed Access | Times Cited: 99
Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
Yingshi Zhang, Dandan Li, Qiyu Jiang, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 7
Open Access | Times Cited: 96
Danger signals in liver injury and restoration of homeostasis
Hui Han, Romain Désert, Sukanta Das, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 4, pp. 933-951
Open Access | Times Cited: 83
Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
Qing Yue, Yu Song, Zi Liu, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4922-4922
Open Access | Times Cited: 56
Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
Haonan Dong, Lu Zhang, Suling Liu
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3421-3434
Open Access | Times Cited: 44
Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches
Mehrdad Hashemi, Niloufar Nadafzadeh, Mohammad Hassan Imani, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Multiple functions of HMGB1 in cancer
Guangyao Lv, Meng‐Lin Yang, Keke Gai, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Machine learning and molecular subtyping reveal the impact of diverse patterns of cell death on the prognosis and treatment of hepatocellular carcinoma
Xinyue Yan, Meng Wang, L. Min Ji, et al.
Computational Biology and Chemistry (2025) Vol. 115, pp. 108360-108360
Closed Access | Times Cited: 1
The progression of HMGB1-induced autophagy in cancer biology
Tianwei Xu, Lihua Jiang, Zhaoxia Wang
OncoTargets and Therapy (2018) Vol. Volume 12, pp. 365-377
Open Access | Times Cited: 71
Is the era of sorafenib over? A review of the literature
Guanghan Fan, Xuyong Wei, Xiao Xu
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 66
Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis
Dong-Jer Shiau, Wan-Ting Kuo, Goutham Venkata Naga Davuluri, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 61
RAGE and its ligands: from pathogenesis to therapeutics
Nitish Jangde, Rashmi Ray, Vivek Rai
Critical Reviews in Biochemistry and Molecular Biology (2020) Vol. 55, Iss. 6, pp. 555-575
Closed Access | Times Cited: 54
Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression
Yadav Sangeeta Muthyalaiah, Bhavana Jonnalagadda, Cordelia Mano John, et al.
Glycoconjugate Journal (2021) Vol. 38, Iss. 6, pp. 717-734
Closed Access | Times Cited: 54
Autophagy, an accomplice or antagonist of drug resistance in HCC?
Yafei Wu, Jigang Zhang, Qin Li
Cell Death and Disease (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 50
Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
Ester Garcia‐Pras, Anabel Fernández‐Iglesias, Jordi Gracia‐Sancho, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 48-48
Open Access | Times Cited: 48
Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma
Danyang Li, Yingcheng Yao, Yuhan Rao, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 34
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
Fengyuan Tang, Ruize Gao, Beena Jeevan-Raj, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 48
Roles of S100 family members in drug resistance in tumors: Status and prospects
Xin Hua, Hongming Zhang, Jinfang Jia, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 127, pp. 110156-110156
Open Access | Times Cited: 48
HMGB1: An overview of its roles in the pathogenesis of liver disease
Yuan-Ao Ni, Hui Chen, Hao Nie, et al.
Journal of Leukocyte Biology (2021) Vol. 110, Iss. 5, pp. 987-998
Closed Access | Times Cited: 37
Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk
Gang Wang, Xiaodi Jiang, Pedram Torabian, et al.
Cancer Letters (2024) Vol. 588, pp. 216744-216744
Open Access | Times Cited: 6
Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled
Ronit Vogt Sionov
Cells (2021) Vol. 10, Iss. 9, pp. 2486-2486
Open Access | Times Cited: 29
RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review
Tabrez Faruqui, Mohd Sajid Khan, Yusuf Akhter, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 266-266
Open Access | Times Cited: 20
Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma
Jimin Dai, Qichao Huang, Kunwei Niu, et al.
Cancer Medicine (2018) Vol. 7, Iss. 11, pp. 5691-5703
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top